Previous 10 | Next 10 |
2023-03-31 09:18:55 ET Ireland-based biotech Amarin Corporation ( NASDAQ: AMRN ) announced Friday that President and Chief Executive Officer Karim Mikhail has decided to step down, effective immediately. Amarin ( AMRN ), the developer of fish oil-derived therapy Vascep...
New Amarin Board Believes the Company Will Thrive with Proper Stewardship New Amarin Directors are Working with Urgency to Address Issues at Amarin DUBLIN, Ireland and BRIDGEWATER, N.J., March 16, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today released the fo...
2023-03-08 18:12:02 ET Amarin Corporation plc (AMRN) Cowen 43rd Annual Healthcare Conference March 08, 2023, 01:30 PM ET Company Participants Karim Mikhail - President and CEO Conference Call Participants Georgi Yordanov - Cowen and Company Presentation...
2023-03-07 10:26:05 ET The following slide deck was published by Amarin Corporation plc in conjunction with their 2022 Q4 earnings call. For further details see: Amarin Corporation plc 2022 Q4 - Results - Earnings Call Presentation
2023-03-06 16:40:33 ET Amarin Corp. ( NASDAQ: AMRN ) said that all seven independent non-Sarissa board members have resigned from the board effective immediately after the activist investor won seven board seats and ousted the Chairman last Tuesday. "Following the 2023 speci...
DUBLIN, Ireland and BRIDGEWATER. N.J., March 06, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that, in the interest of the Company to avoid further proxy contests, all seven independent non-Sarissa board mem...
2023-03-06 10:53:39 ET Amarin Corp. ( NASDAQ: AMRN ), maker of the prescription fish oil pill Vascepa, has unviled in vitro data it says supports the potential mechanistic effects of omega-3 fatty acid eicosapentaenoic acid (EPA) in reducing cardiovascular event. ...
--In Vitro Data Presentations Support Antithrombotic and Antioxidant Effects of EPA Compared with DHA, No Impact of Mineral Oil on Rates of LDL Oxidation -– DUBLIN, Ireland and BRIDGEWATER, N.J., March 06, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today high...
--Post-Hoc Analysis Shows IPE Significantly Reduced Risk of First, Total Ischemic Events by 37% and 36% Respectively in Patients with Recent ACS Without Increased Bleeding-- --Analysis Builds on Consistently Demonstrated Positive Outcomes for VASCEPA/VAZKEPA Across Sub-Populations in RE...
Alkermes Plc ( NASDAQ: ALKS ) rose 2.6% amid speculation that activist Sarissa Capital Management could target the company in a possible proxy battle after a win on Tuesday against Amarin ( AMRN ). Sarissa, which is one of Alkermes ( ALKS ) biggest holders with 14 million ...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...